Downloadable slides of key HIV studies presented at IDWeek, HIV Comorbidities Workshop, and HIV Glasgow 2018, reported by Clinical Care Options
Expert audio analysis by David A. Wohl, MD, of key HIV studies presented at IDWeek 2018 and HIV Glasgow 2018 as reported by Clinical Care Options
Analysis from Glasgow 2018 finds no increased risk of neural tube defects with elvitegravir or bictegravir during pregnancy, reported by Clinical Care Options (CCO).
SMARTT: neurologic diagnoses in HIV-exposed, uninfected children exposed to prenatal ARVs, presented at IDWeek 2018, reported by Clinical Care Options
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.